We are monitoring the impact of COVID-19 & Recession alarm on Europe Tissue Diagnostics Market Get in touch with us for detailed analysis Know More

Know More

Share on

Europe Tissue Diagnostics Market Research Report - Segmented By Product Type, Application, End User, Disease & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 4091
Pages: 130

Europe Tissue Diagnostics Market Size (2022 to 2027)

According to the research report, the Europe Tissue Diagnostics Market size is estimated to be worth USD 1.56 billion by 2027 and USD 1.13 billion in 2022, growing at a CAGR of 6.70% during the forecast period.

The rising prevalence of cancer, the improving infrastructure for cancer detection, the recommendation of cancer screening, the availability of reimbursements, and rising healthcare expenditures are all driving this European tissue diagnostics market forward. Increased use of automated tissue diagnostics to detect illnesses such as cancer, increased healthcare spending, and growth in the cancer population are some of the reasons driving the market forward throughout the forecast period. Furthermore, the rise in the geriatric population, which is more susceptible to immunological diseases, and the increased usage of customized medications to treat different chronic conditions, such as cancer, fuel the diagnostics market in Europe. Tissue diagnostics captures the disease insights and factors that influence patient outcomes. Tissues, in general, provide for individualized diagnosis and therapy. The majority of samples are made up of tissue fragments acquired through various procedures. Small biopsies and big specimens extracted during surgery are instances.

Increased tissue diagnostics in hospitals for cancer monitoring, diagnosis, and management at various stages, including breast cancer, prostate cancer, and other cancers. Because these methods capture the biological environment of malignancies, tissue diagnostics remains one of the gold standards for cancer diagnosis. With the rise in cancer cases, the market for tissue diagnostics has seen a surge in demand, with promising development prospects in the near future. For the development of innovative tests, personalized medicine heavily relies on the utilization of human tissue. The use of tissue diagnostics is driven by an increase in the deployment of sequencing technologies and healthcare IT systems in the clinical workflow, which has greatly extended customized medicine. In addition, the growing disease burden is driving the demand for effective and rapid treatment alternatives, which is likely to drive European tissue diagnostics market growth during the forecast period.

The rising cost of tissue diagnostics equipment and the rising cost of treatment is expected to hamper the growth rate of the European tissue diagnostics market. In addition, government regulations and unfavorable reimbursement policies are expected to limit the diagnostics market's growth in Europe.

This research report on the European Tissue Diagnostics Market has been segmented and sub-segmented into the following categories:

By Product Type: 

  • Instruments
  • Consumables

By Application: 

  • Immunohistochemistry
  • Hematoxylin and Eosin
  • In Situ Hybridization

By End User: 

  • Contract Research Organizations
  • Hospitals
  • Diagnostic Laboratories
  • Research Organizations
  • Biotechnology Companies

By Disease: 

  • Lung Cancer
  • Lymphoma
  • Pancreatic Cancer
  • Breast Cancer
  • Others

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Geographically, The tissue diagnostic market in the European area is growing due to increased public programs to reduce cancer risk and a rise in cancer demand. In addition, due to an increase in the prevalence of infectious illnesses, immunodiagnostics in infectious disease diagnosis has increased. Other factors that contribute to the growth of the German tissue diagnostics market include the increased usage of fast tests such as continuous glucose monitoring and flash glucose monitoring. The easy availability of advanced technologies, government initiatives for cancer patient screening, favorable reimbursement scenarios for pathology diagnostic tests, rising healthcare expenditures, and high-quality infrastructure for hospitals and clinical laboratories in this region are the major factors driving the tissue diagnostic market's growth in Europe.

KEY MARKET PLAYERS:

A few of the promising companies operating in the Europe Tissue diagnostics Market profiled in this report are F. Hoffmann-La Roche AG, Sigma-Aldrich Co. LLC, Abbott Laboratories, Agilent Technologies, BioGenex, Danaher Corporation, Cell Signaling Technology, and Ventana Medical Systems.

1. Introduction                                        

                1.1 Market Definition                           

                1.2 Study Deliverables                         

                1.3 Base Currency, Base Year and Forecast Periods      

                1.4 General Study Assumptions                       

2. Research Methodology         

                2.1 Introduction                                      

                2.2 Research Phases                             

                                2.2.1 Secondary Research                  

                                2.2.2 Primary Research        

                                2.2.3 Econometric Modelling             

                                2.2.4 Expert Validation         

                2.3 Analysis Design                                

                2.4 Study Timeline                                 

3. Overview     

                3.1 Executive Summary                       

                3.2 Key Inferences                                

                3.3 Epidemology                                     

4. Drivers, Restraints, Opportunities, and Challenges Analysis  (DROC)         

                4.1 Market Drivers                                 

                4.2 Market Restraints                           

                4.3 Key Challenges                                

                4.4 Current Opportunities in the Market                   

5. Market Segmentation            

                5.1 Product type                                     

                                5.1.1 Introduction                  

                                5.1.2 Instruments                  

       5.1.2.1 Microscope

       5.1.2.2 Non-contact Handheld IR Thermometer        

       5.1.2.3 Haemocytometer    

       5.1.2.4 NMR Tube  

       5.1.2.5 Others                                   

                                5.1.3 Consumables                

       5.1.3.1 Reagent kits                                        

       5.1.3.2 Others                                   

                                5.1.4  Y-o-Y Growth Analysis, By Product type           

                                5.1.5 Market Attractiveness Analysis, By Product type         

                                5.1.6 Market Share Analysis, By Product type           

                5.2 Disease                               

                                5.2.1 Introduction                  

                                5.2.2 Lung cancer                   

                                5.2.3 Lymphoma                     

                                5.2.4 Pancreatic cancer        

                                5.2.5 Breast cancer                

                                5.2.6 Others             

                                5.2.7 Y-o-Y Growth Analysis, By Disease       

                                5.2.8 Market Attractiveness Analysis, By Disease                     

                                5.2.9 Market Share Analysis, By Disease      

                5.3 Application                        

                                5.3.1 Introduction                  

                                5.3.2 Hematoxylin and Eosin             

                                5.3.3 Immunohistochemistry            

                                5.3.4 In Situ Hybridization                   

                                5.3.5 Y-o-Y Growth Analysis, By Application                

                                5.3.6  Market Attractiveness Analysis, By Application             

                                5.3.7  Market Share Analysis, By Application              

                5.4 End user                             

                                5.4.1 Introduction                  

                                5.4.2 Hospitals         

                                5.4.3 Diagnostic laboratories             

                                5.4.4 Research Organizations            

                                5.4.5 Contract Research Organizations          

                                5.4.6 Biotechnology Companies       

                                5.4.7 Y-o-Y Growth Analysis, By End user                     

                                5.4.8  Market Attractiveness Analysis, By End user                  

                                5.4.9  Market Share Analysis, By End user                   

6. Geographical Analysis            

                6.1 Introduction                                      

                                6.1.1 Regional Trends           

                                6.1.2 Impact Analysis            

                                6.1.3 Y-o-Y Growth Analysis               

       6.1.3.1 By Geographical Area                                     

       6.1.3.2 By Product type                                

       6.1.3.3 By Disease  

       6.1.3.4 By Application                                    

       6.1.3.5 By End user

                                6.1.4  Market Attractiveness Analysis            

       6.1.4.1 By Geographical Area                                     

       6.1.4.2 By Product type                                

       6.1.4.3 By disease  

       6.1.4.4 By Application                                    

       6.1.4.5 By End user

                                6.1.5  Market Share Analysis             

       6.1.5.1 By Geographical Area                                     

       6.1.5.2 By Product type                                

       6.1.5.3 By Disease  

       6.1.5.4 By Application                                    

       6.1.5.5 By End user

                6.2 U.K                        

                6.3 Spain                                    

                6.4 Germany                            

                6.5 Italy                                      

                6.6 France                                 

7. Strategic Analysis     

                7.1 PESTLE analysis                                

                                7.1.1 Political            

                                7.1.2 Economic        

                                7.1.3 Social                

                                7.1.4 Technological                

                                7.1.5 Legal                 

                                7.1.6 Environmental              

                7.2 Porter’s Five analysis                                     

                                7.2.1 Bargaining Power of Suppliers               

                                7.2.2 Bargaining Power of Consumers           

                                7.2.3 Threat of New Entrants            

                                7.2.4 Threat of Substitute Products and Services                     

                                7.2.5 Competitive Rivalry within the Industry            

8. Market Leaders' Analysis      

                8.1 F. Hoffmann-La Roche AG                           

                                8.1.1 Overview        

                                8.1.2 Product Analysis          

                                8.1.3 Financial analysis         

                                8.1.4 Recent Developments              

                                8.1.5 SWOT analysis              

                                8.1.6 Analyst View                 

                8.2 Sigma-Aldrich Co. LLC                                    

                8.3 Abbott Laboratories                      

                8.4 Agilent Technologies                                     

                8.5 BioGenex                  

 

  1. Europe Tissue diagnostics Market, By Product type, From 2022 - 2027 (USD Million)
  2. Europe Instruments Market, By Region, From 2022 - 2027 (USD Million)
  3. Europe Consumables Market, By Region, From 2022 - 2027 (USD Million)
  4. Europe Tissue diagnostics Market, By Disease, From 2022 - 2027 (USD Million)
  5. Europe Lung cancer Market, By Region, From 2022 - 2027 (USD Million)
  6. Europe Lymphoma Market, By Region, From 2022 - 2027 (USD Million)
  7. Europe Pancreatic cancer Market, By Region, From 2022 - 2027 (USD Million)
  8. Europe Breast cancer Market, By Region, From 2022 - 2027 (USD Million)
  9. Europe Others Market, By Region, From 2022 - 2027 (USD Million)
  10. Europe Tissue diagnostics Market, By Application, From 2022 - 2027 (USD Million)
  11. Europe Hematoxylin and Eosin Market, By Region, From 2022 - 2027 (USD Million)
  12. Europe Immunohistochemistry Market, By Region, From 2022 - 2027 (USD Million)
  13. Europe In Situ Hybridization Market, By Region, From 2022 - 2027 (USD Million)
  14. Europe Tissue diagnostics Market, By End user, From 2022 - 2027 (USD Million)
  15. Europe Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  16. Europe Diagnostic laboratories Market, By Region, From 2022 - 2027 (USD Million)
  17. Europe Research Organizations Market, By Region, From 2022 - 2027 (USD Million)
  18. Europe Contract Research Organizations Market, By Region, From 2022 - 2027 (USD Million)
  19. Europe Biotechnology Companies Market, By Region, From 2022 - 2027 (USD Million)
  20. U.K. Tissue diagnostics Market, By Product type, From 2022 - 2027 (USD Million)
  21. U.K. Tissue diagnostics Market, By Disease, From 2022 - 2027 (USD Million)
  22. U.K. Tissue diagnostics Market, By Application, From 2022 - 2027 (USD Million)
  23. U.K. Tissue diagnostics Market, By End user, From 2022 - 2027 (USD Million)
  24. Germany Tissue diagnostics Market, By Product type, From 2022 - 2027 (USD Million)
  25. Germany Tissue diagnostics Market, By Disease, From 2022 - 2027 (USD Million)
  26. Germany Tissue diagnostics Market, By Application, From 2022 - 2027 (USD Million)
  27. Germany Tissue diagnostics Market, By End user, From 2022 - 2027 (USD Million)
  28. France Tissue diagnostics Market, By Product type, From 2022 - 2027 (USD Million)
  29. France Tissue diagnostics Market, By Disease, From 2022 - 2027 (USD Million)
  30. France Tissue diagnostics Market, By Application, From 2022 - 2027 (USD Million)
  31. France Tissue diagnostics Market, By End user, From 2022 - 2027 (USD Million)
  32. Italy Tissue diagnostics Market, By Product type, From 2022 - 2027 (USD Million)
  33. Italy Tissue diagnostics Market, By Disease, From 2022 - 2027 (USD Million)
  34. Italy Tissue diagnostics Market, By Application, From 2022 - 2027 (USD Million)
  35. Italy Tissue diagnostics Market, By End user, From 2022 - 2027 (USD Million)
  36. Spain Tissue diagnostics Market, By Product type, From 2022 - 2027 (USD Million)
  37. Spain Tissue diagnostics Market, By Disease, From 2022 - 2027 (USD Million)
  38. Spain Tissue diagnostics Market, By Application, From 2022 - 2027 (USD Million)
  39. Spain Tissue diagnostics Market, By End-user, From 2022 - 2027 (USD Million)
  40. Europe Tissue Diagnostics Market, By Instruments, From 2022 - 2027 (USD Million)
  41. Europe Microscope Market, By Region, From 2022 - 2027 (USD Million)
  42. Europe Non-contact Handheld IR Thermometer Market, By Region, From 2022 - 2027 (USD Million)
  43. Europe Haemocytometer Market, By Region, From 2022 - 2027 (USD Million)
  44. Europe NMR Tube Market, By Region, From 2022 - 2027 (USD Million)
  45. Europe Others Market, By Region, From 2022 - 2027 (USD Million)
  46. U.K. Tissue diagnostics Market, By Instruments, From 2022 - 2027 (USD Million)
  47. Germany Tissue diagnostics Market, By Instruments, From 2022 - 2027 (USD Million)
  48. France Tissue diagnostics Market, By Instruments, From 2022 - 2027 (USD Million)
  49. Italy Tissue diagnostics Market, By Instruments, From 2022 - 2027 (USD Million)
  50. Spain Tissue diagnostics Market, By Instruments, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

pdf
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample